Quality Without Complexity: Interviewing Dipesh Patel
“Giving people enough space and a safe environment to do their job and innovate is fulfilling for them, and they will then, inevitably, develop solutions to the most pressing needs.”
Clinical Scorecard: Quality Without Complexity: Interviewing Dipesh Patel
At a Glance
Category Detail
Condition Quality in drug development Key Mechanisms Human-centered approach, data-driven decision-making, risk management Target Population CDMOs, biotech start-ups, large-scale pharmaceutical manufacturing Care Setting Quality management in drug development
Key Highlights
Emphasis on a compelling common vision for quality organizations Importance of a safe environment for innovation Focus on simplicity and efficiency in quality systems Need for strong internal and external partnerships Emerging trends include AI adoption and precision medicine Guideline-Based Recommendations
Diagnosis
Define quality in practical terms Build mature capability in quality risk management Management
Maintain robust yet simple processes Support growth in new modalities and services Monitoring & Follow-up
Use data and scientific expertise to evaluate processes Adapt risk assessments for focused clinical programs Risks
Avoid unnecessary complexity that does not add value Ensure compliance in a dynamic regulatory environment Patient & Prescribing Data
Patients involved in clinical trials
Focus on patient safety and efficacy outcomes through quality assurance
Clinical Best Practices
Foster a culture of common-sense compliance Encourage continuous improvement mindset Align Quality and bioanalytical teams closely References
